Ocumension Therapeutics (1477.HK)

HKD 5.45

(8.57%)

Total Debt Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual total debt in 2023 was 137.98 Million CNY , up 366.52% from previous year.
Ocumension Therapeutics's latest quarterly total debt in 2023 FY was 137.98 Million CNY , up 366.52% from previous quarter.
Ocumension Therapeutics reported annual total debt of 29.57 Million CNY in 2022, up 163.8% from previous year.
Ocumension Therapeutics reported annual total debt of 11.21 Million CNY in 2021, up 54.95% from previous year.
Ocumension Therapeutics reported quarterly total debt of 137.98 Million CNY for 2023 Q4, up 9.81% from previous quarter.
Ocumension Therapeutics reported quarterly total debt of 24.45 Million CNY for 2023 Q2, up 115.84% from previous quarter.

Annual Total Debt Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Total Debt of Ocumension Therapeutics (2023 - 2018)

Year	Total Debt	Total Debt Growth
2023	137.98 Million CNY	366.52%
2022	29.57 Million CNY	163.8%
2021	11.21 Million CNY	54.95%
2020	7.23 Million CNY	474.74%
2019	1.25 Million CNY	11.81%
2018	1.12 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2023 Q1	11.33 Million CNY	-61.69%
2023 Q4	137.98 Million CNY	9.81%
2023 Q2	24.45 Million CNY	115.84%
2023 Q3	125.65 Million CNY	413.83%
2023 FY	137.98 Million CNY	366.52%
2022 Q1	25.16 Million CNY	124.48%
2022 Q4	29.57 Million CNY	71.04%
2022 Q3	17.29 Million CNY	-57.32%
2022 Q2	40.51 Million CNY	60.97%
2022 FY	29.57 Million CNY	163.8%
2021 Q1	8.43 Million CNY	16.5%
2021 FY	11.21 Million CNY	54.95%
2021 Q3	7.02 Million CNY	-43.96%
2021 Q2	12.53 Million CNY	48.72%
2021 Q4	11.21 Million CNY	59.58%
2020 Q3	5.3 Million CNY	798.31%
2020 Q4	7.23 Million CNY	36.3%
2020 FY	7.23 Million CNY	474.74%
2020 Q1	4.83 Billion CNY	383572.04%
2020 Q2	591 Thousand CNY	-99.99%
2019 Q1	- CNY	0.0%
2019 Q4	1.25 Million CNY	-99.96%
2019 Q3	3.31 Billion CNY	0.0%
2019 FY	1.25 Million CNY	11.81%
2018 FY	1.12 Million CNY	0.0%

Peer Total Debt Comparison of Ocumension Therapeutics

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	-161.0%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	97.674%